RxDoctor Payments Data

Olga Kovacevic, MD

Family Medicine · Strongsville, OHNPI 1487630323

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.8% of the total across 583 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 41 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,953 and has fallen 89.9% since, to $197 in 2024. Among family medicine clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,459in general payments, 2019–2025

Across 583 payments — averaging $14.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • AstraZeneca$1K
  • Novo Nordisk$884
  • Pfizer$776
  • Lilly USA, LLC$501
  • Merck$376
  • plus $3K from 35 others

What the payments were for

  • Food & beverage$8,35999%
  • Education$1001%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,459 in reported general payments places this provider in the 90th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio →

Medicare billing

Part B allowed, 2024
$7,345
Medicare patients
53
Services billed
82

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate14$14,424
Atorvastatin Calcium102$833
Levothyroxine Sodium63$761
Bisoprolol-HydrochlorothiazideBisoprolol/Hydrochlorothiazide16$605
Metoprolol Succinate39$561
Losartan Potassium56$512
Lisinopril65$487
Omeprazole29$392
Simvastatin48$382
Pantoprazole Sodium20$341
Sertraline Hcl37$309
Amlodipine Besylate65$274
Trazodone Hcl26$255
Metformin Hcl44$242
Rosuvastatin Calcium23$207

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$376$14,42414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Strongsville

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →